WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Rex W. Watkins
Of Counsel
Patents and Innovations
rwatkins@wsgr.com

D650-849-3144

Download vCard
Open PDF
  • Strategic Patent Counselor

    Rex provides a holistic IP strategy to life science companies.

  • IP Deal Expertise

    Rex advises clients on IP matters relating to financing, M&A, and partnership deals.

Dr. Rex Watkins is Of Counsel at Wilson Sonsini Goodrich & Rosati, where his practice focuses on patent procurement—both domestic and international—for clients in the life sciences. Rex has extensive experience in patent counseling, patent drafting and prosecution, freedom-to-operate analyses, validity and infringement opinions, IP due diligence, patent litigation, and licensing.

Rex’s technical expertise extends across the life sciences industry, including biologics, genetics, fluorescence, small molecules, peptides, drug-delivery systems, antisense nucleic acids, microarrays, RNA technologies, vaccines, chemical synthesis, polymer chemistry, and organometallic catalysts. He also has significant patent prosecution experience with medical devices, including vascular access technologies, stents, inflation systems, and embolics.

Prior to joining the firm, Rex was a judicial extern for Judge Randall R. Radar of the U.S. Court of Appeals for the Federal Circuit. He also has experience as a research assistant at Utah State University and as an intern at a small biotechnology company.

Rex is practicing virtually in Utah, where he is licensed.

Experience

Dr. Rex Watkins is Of Counsel at Wilson Sonsini Goodrich & Rosati, where his practice focuses on patent procurement—both domestic and international—for clients in the life sciences. Rex has extensive experience in patent counseling, patent drafting and prosecution, freedom-to-operate analyses, validity and infringement opinions, IP due diligence, patent litigation, and licensing.

Rex’s technical expertise extends across the life sciences industry, including biologics, genetics, fluorescence, small molecules, peptides, drug-delivery systems, antisense nucleic acids, microarrays, RNA technologies, vaccines, chemical synthesis, polymer chemistry, and organometallic catalysts. He also has significant patent prosecution experience with medical devices, including vascular access technologies, stents, inflation systems, and embolics.

Prior to joining the firm, Rex was a judicial extern for Judge Randall R. Radar of the U.S. Court of Appeals for the Federal Circuit. He also has experience as a research assistant at Utah State University and as an intern at a small biotechnology company.

Rex is practicing virtually in Utah, where he is licensed.

Education
  • J.D., J. Reuben Clark Law School, Brigham Young University, 2013Magna Cum Laude; Senior Editor, BYU Law Review
  • Ph.D., Biochemistry, University of Wisconsin-Madison, 2010NSF Graduate Research Fellow
  • B.S., Chemistry, Utah State University, 2005Summa Cum Laude
Associations and Memberships
  • Committee Member and Giles Rich Moot Court Competition Liaison, Intellectual Property Section, Utah State Bar, 2015-2016
  • Subcommittee Chair, Utah Innovation Awards, Biotechnology and Medical Devices, 2014-2016
  • Member, American Chemical Society, 2004-2016
Admissions
  • State Bar of California
  • State Bar of Utah
  • U.S. Patent and Trademark Office
Credentials
Education
  • J.D., J. Reuben Clark Law School, Brigham Young University, 2013Magna Cum Laude; Senior Editor, BYU Law Review
  • Ph.D., Biochemistry, University of Wisconsin-Madison, 2010NSF Graduate Research Fellow
  • B.S., Chemistry, Utah State University, 2005Summa Cum Laude
Associations and Memberships
  • Committee Member and Giles Rich Moot Court Competition Liaison, Intellectual Property Section, Utah State Bar, 2015-2016
  • Subcommittee Chair, Utah Innovation Awards, Biotechnology and Medical Devices, 2014-2016
  • Member, American Chemical Society, 2004-2016
Admissions
  • State Bar of California
  • State Bar of Utah
  • U.S. Patent and Trademark Office

Select Publications

  • Co-author with V. Norviel, L. Lieto, D. Hoffmeister, G. Ravitz, J. Ravitz, and C. Andres, "Citizen Petitions are Crucial in Managing A Drug’s Life Cycle," Law360, November 8, 2019
  • Co-author, "Ribonuclease S redux," 47(3) Chemical Communications 973-5, 2011
  • Co-author, "Fluorogenic affinity label for the facile, rapid imaging of proteins in live cells," 7(19) Organic & Biomolecular Chemistry 3969-75, 2009
  • Co-author, "Divalent metal complexes of an amide-appended N3O-donor ligand: Synthesis, structural and spectroscopic features, and amide methanolyisis reactivity," 61(1) Journal of Coordination Chemistry 61-77, 2008
  • Co-author, "Amide hydrolysis reactivity of a N4O-ligated zinc complex: Comparison of kinetic and thermodynamic parameters with those of the corresponding amide methanolysis reaction," 46(7) Inorganic Chemistry 2353-5, 2006
  • Co-author, "Synthesis and characterization of a series of N3O-ligated mononuclear Mn(II) halide complexes," 359(4) Inorganica Chimica Acta 1282-90, 2006
  • Co-author, "Manganese (II) chemistry of a new N3O-donor chelate ligand: Synthesis, X-ray structures, and magnetic properties of solvent- and oxalate-bound complexes," 11 Dalton Transactions 1891-6, 2005
  • Co-author, "Mononuclear nitrogen/sulfur-ligated cobalt(II) methoxide complexes: Structural, EPR, paramagnetic 1H NMR, and electrochemical investigations," 16 Dalton Transactions 2398-9, 2004
Insights

Select Publications

  • Co-author with V. Norviel, L. Lieto, D. Hoffmeister, G. Ravitz, J. Ravitz, and C. Andres, "Citizen Petitions are Crucial in Managing A Drug’s Life Cycle," Law360, November 8, 2019
  • Co-author, "Ribonuclease S redux," 47(3) Chemical Communications 973-5, 2011
  • Co-author, "Fluorogenic affinity label for the facile, rapid imaging of proteins in live cells," 7(19) Organic & Biomolecular Chemistry 3969-75, 2009
  • Co-author, "Divalent metal complexes of an amide-appended N3O-donor ligand: Synthesis, structural and spectroscopic features, and amide methanolyisis reactivity," 61(1) Journal of Coordination Chemistry 61-77, 2008
  • Co-author, "Amide hydrolysis reactivity of a N4O-ligated zinc complex: Comparison of kinetic and thermodynamic parameters with those of the corresponding amide methanolysis reaction," 46(7) Inorganic Chemistry 2353-5, 2006
  • Co-author, "Synthesis and characterization of a series of N3O-ligated mononuclear Mn(II) halide complexes," 359(4) Inorganica Chimica Acta 1282-90, 2006
  • Co-author, "Manganese (II) chemistry of a new N3O-donor chelate ligand: Synthesis, X-ray structures, and magnetic properties of solvent- and oxalate-bound complexes," 11 Dalton Transactions 1891-6, 2005
  • Co-author, "Mononuclear nitrogen/sulfur-ligated cobalt(II) methoxide complexes: Structural, EPR, paramagnetic 1H NMR, and electrochemical investigations," 16 Dalton Transactions 2398-9, 2004

Biological Sciences and Biotechnology

  • Antibody
  • Biochemical assays
  • Biochemistry
  • Bioconjugation
  • Biologics
  • Cancer biology
  • Cancer therapeutics
  • Cell biology
  • Cell culture products
  • Cell therapy
  • Cellular biology
  • Cellular immunology
  • Epigenetics
  • Genetics
  • Molecular biology
  • Molecular genetics
  • PCR

Therapeutics and Drug Discovery

  • Biosimilars
  • Drug conjugates
  • Drug conjugates based drug discovery
  • Gene editing
  • Gene therapy
  • Pharmacodynamics
  • Pharmacokinetics

Diagnostics and Medical Devices

  • Diagnostics
  • Medical devices

Chemistry and Material Science

  • Protein engineering

Genomics and Data Analysis

  • Sequencing
Technical Fluency

Biological Sciences and Biotechnology

  • Antibody
  • Biochemical assays
  • Biochemistry
  • Bioconjugation
  • Biologics
  • Cancer biology
  • Cancer therapeutics
  • Cell biology
  • Cell culture products
  • Cell therapy
  • Cellular biology
  • Cellular immunology
  • Epigenetics
  • Genetics
  • Molecular biology
  • Molecular genetics
  • PCR

Therapeutics and Drug Discovery

  • Biosimilars
  • Drug conjugates
  • Drug conjugates based drug discovery
  • Gene editing
  • Gene therapy
  • Pharmacodynamics
  • Pharmacokinetics

Diagnostics and Medical Devices

  • Diagnostics
  • Medical devices

Chemistry and Material Science

  • Protein engineering

Genomics and Data Analysis

  • Sequencing
Focus Areas
  • Biotech
  • Intellectual Property
  • Life Sciences
  • Medical Devices
  • Patents and Innovations
Recent Insights
Client Highlights
Wilson Sonsini Advises Excellergy on $2 Billion Acquisition by Novartis
On March 27, 2026, Excellergy, a biotechnology company developing a novel class of allergy therapeutics, announced it will be acquired by Novartis in a transaction with a total potential value of up to $2 billion in upfront and milestone payments. The acquisition brings together Excellergy's novel trifunctional ECRIs with the development expertise of Novartis. Wilson Sonsini Goodrich & Rosati advised Excellergy on the transaction.
Learn More
Client Highlights
Firm Advises Arcellx on $7.8 Billion Acquisition by Gilead
On February 23, 2026, Gilead Sciences announced that it has entered into a definitive agreement to acquire Arcellx, a biotechnology company focused on delivering a new class of innovative immunotherapies for patients with cancer and other incurable diseases, for $115 per share in cash at closing and one contingent value right of $5 per share, which represents an implied equity value of $7.8 billion payable at closing. Wilson Sonsini Goodrich & Rosati advised Arcellx on the transaction.
Learn More
View All
Recent Events
Affiliated Programs
2025 Entrepreneur and Investor Life Sciences Summit (E&I Summit), presented by BioUtah
Wilson Sonsini is looking forward to the 2025 Entrepreneur & Investor Life Sciences Summit (E&I Summit), presented by BioUtah and the University of Utah Technology Licensing Office. Now in its 12th year, the E&I Summit convenes Utah’s life sciences leaders, entrepreneurs, and the investor community.
Learn More
WSGR Events
Startup Bootcamp for Entrepreneurs
Wilson Sonsini is pleased to partner with Biohive, BioUtah, and The University of Utah PIVOT Center to host a Startup Bootcamp for Entrepreneurs. This is an exclusive one-day program designed for those in the process of—or considering—starting a new venture. Join us for this unique event that will provide practical information on the most important legal and business issues facing today’s entrepreneurs.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.